Previous study also showed that the chemotherapy-sensitive Hodgkin lymphoma patients had frequent gains of 16q13, a chromosomal region known to house genes that regulate T-cells trafficking or NF-ĸB activation (CX3CL1, CCL22, CCL17, DOK4, and IL10) (Slovak et al., 2011). The gene discussed is CCL22; the disease is Hodgkins lymphoma.